Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.11 EUR
Change Today 0.00 / 0.00%
Volume 47.0K
As of 1:21 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

sunwin stevia international (S1N) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/11/14 - €0.20
52 Week Low
04/14/14 - €0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sunwin stevia international (S1N) Related Businessweek News

No Related Businessweek News Found

sunwin stevia international (S1N) Details

Sunwin Stevia International, Inc. produces and sells stevioside, a natural sweetener; and herbs used in traditional Chinese medicines and veterinary products primarily in the People’s Republic of China. It operates in two segments, Stevioside and Chinese Medicines. The Stevioside segment produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. Its products include Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, dietary supplement. This segment’s products are used to replace sugar in beverages and foods; and various consumer products, such as soft drinks, vegetable products, tabletop sweeteners, confectioneries, fruit products, and processed seafood products in the United States, Japan, South Korea, China, Taiwan, India, Indonesia, Israel, Germany, France, Brazil, Paraguay, Malaysia, Russia, Switzerland, Australia, and New Zealand. It sells its products to food and drug manufacturers and ingredient distributor foreign trade companies. The Chinese Medicine segment manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by humans and animals. Its extracts consists of single traditional Chinese medicine extracts; compound traditional Chinese medicine extracts; and purified extracts, including active parts and monomer compounds, such as soy isoflavone. This segment offers Chinese medicine formula extracts to traditional Chinese medicine manufacturers and animal pharmaceutical manufacturers. The company was formerly known as Sunwin International Neutraceuticals, Inc. and changed its name to Sunwin Stevia International, Inc. in April 2012. Sunwin Stevia International, Inc. is based in Qufu, China.

203 Employees
Last Reported Date: 07/30/14

sunwin stevia international (S1N) Top Compensated Officers

Chief Executive Officer, Secretary and Direct...
Total Annual Compensation: $63.1K
Chairman and President
Total Annual Compensation: $33.0K
Compensation as of Fiscal Year 2014.

sunwin stevia international (S1N) Key Developments

Sunwin Stevia International, Inc. announced delayed 10-Q filing

On 12/15/2014, Sunwin Stevia International, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Sunwin Stevia International, Inc. Auditor Raises 'Going Concern' Doubt

Sunwin Stevia International, Inc. filed its 10-K on Jul 29, 2014 for the period ending Apr 30, 2014. In this report its auditor, Russell Bedford Stefanou Mirchandani LLP - RBSM LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Sunwin Stevia International, Inc. Now Producing Rebaudioside A 99.8% Stevioside Extracts

Sunwin Stevia International, Inc. announced that the company is now producing Rebaudioside A 99.8% stevioside extracts (RA 99.8) and has delivered 4,400 kilograms to a US based customer. RA 99.8 extracts are currently the higher quality stevioside extracts produced in the world. Sunwin Stevia completed the testing of its production of RA 99.8 early in the first quarter of fiscal 2014. The company completed delivery of 4,400 kilograms of RA 99.8 into the United States in the third quarter of fiscal 2014 and has now successfully added it to the company's commercial product offerings. Sunwin Stevia generated approximately $450,000 in revenue from the completion of delivery to this US based customer. RA 99.8% is one of the higher margin products produced by Sunwin Stevia, and through significant investment at its production facility the company has now positioned itself as a leading global source of this high quality stevia extract.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
S1N:GR €0.11 EUR 0.00

S1N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GLG Life Tech Corp C$0.30 CAD +0.02
PureCircle Ltd 518.50 GBp -1.50
View Industry Companies

Industry Analysis


Industry Average

Valuation S1N Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.1x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNWIN STEVIA INTERNATIONAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at